New Japanese medicine for dental restoration: innovations in dentistry

A team of researchers from Japan’s Kitano Hospital has unveiled a new breakthrough drug designed to restore tooth growth. This drug will be the world’s first drug designed to treat congenital edentia – a condition in which molars do not begin to grow.

Currently, about 1% of people in the world suffer from congenital adentia, which can be either complete or partial. The new drug aims to treat the effects of this disease by targeting the USAG-1 protein, which inhibits tooth growth.